Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ et al (2012) Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropath Exp Neurol 71:362–381
Article
Google Scholar
LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloid-beta in Alzheimer's disease. Nat Rev Neurosci 8:499–509
CAS
Article
Google Scholar
Lee SJC, Nam E, Lee HJ, Savelieff MG, Lim MH (2017) Towards an understanding of amyloid-beta oligomers: characterization, toxicity mechanisms, and inhibitors. Chem Soc Rev 46:310–323
CAS
Article
Google Scholar
Karran E, Mercken M, De Strooper B (2011) The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 10:698–712
CAS
Article
Google Scholar
Zlokovic BV (2005) Neurovascular mechanisms of Alzheimer’s neurodegeneration. Trends Neurosci 28:202–208
CAS
Article
Google Scholar
Madadi S, Schwarzenbach H, Saidijam M, Mahjub R, Soleimani M (2019) Potential microRNA-related targets in clearance pathways of amyloid-β: novel therapeutic approach for the treatment of Alzheimer's disease. Cell Biosci 9:91
Article
Google Scholar
Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B et al (2000) Clearance of Alzheimer’s amyloid-β 1–40 peptide from brain by LDL receptor–related protein-1 at the blood-brain barrier. J Clin Invest 106(12):1489–1499
CAS
Article
Google Scholar
Mackic JB, Stins M, McComb JG, Calero M, Ghiso J, Kim KS et al (1998) Human blood-brain barrier receptors for Alzheimer’s amyloid-beta 1–40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. J Clin Invest 102(4):734–743
CAS
Article
Google Scholar
Selkoe DJ (2004) American College of Physicians and American Physiological Society, Alzheimer disease: mechanistic understanding predicts novel therapies. Ann Intern Med 140:627–638
CAS
Article
Google Scholar
Lam FC, Liu R, Lu P, Shapiro AB, Renoir JM, Sharom FJ et al (2001) Beta-amyloid efflux mediated by p-glycoprotein. J Neurochem 76:1121–1128
CAS
Article
Google Scholar
Kuhnke D, Jedlitschky G, Grube M, Krohn M, Jucker M, Mosyagin I et al (2007) MDR1-P-glycoprotein (ABCB1) mediates transport of Alzheimer's amyloid-beta peptides—implications for the mechanisms of Abeta clearance at the blood-brain barrier. Brain Pathol 17:347–353
CAS
Article
Google Scholar
Calabrese V, Stella AM, Butterfield DA, Scapagnini G (2004) Redox regulation in neurodegeneration and longevity: role of the heme oxygenase and HSP70 systems in brain stress tolerance. Antioxid Redox Signal 6:895–913
CAS
PubMed
Google Scholar
Brenn A, Grube M, Peters M, Fischer A, Jedlitschky G, Kroemer HK et al (2011) beta-Amyloid downregulates MDR1-P-glycoprotein (Abcb1) expression at the blood-brain barrier in mice. Int J Alzheimers Dis 2011:690121
PubMed
PubMed Central
Google Scholar
Shubbar MH, Penny JI (2018) Effect of amyloid beta on ATP-binding cassette transporter expression and activity in porcine brain microvascular endothelial cells. Biochim Biophys Acta Gen Subj 1862:2314–2322
CAS
Article
Google Scholar
Hartz AM, Miller DS, Bauer B (2010) Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease. Mol Pharmacol 77:715–723
CAS
Article
Google Scholar
Qosa H, Batarseh YS, Mohyeldin MM, El Sayed KA, Keller JN, Kaddoumi A (2015) Oleocanthal enhances amyloid-beta clearance from the brains of TgSwDI mice and in vitro across a human blood-brain barrier model. ACS Chem Neurosci 6:1849–1859
CAS
Article
Google Scholar
Brenn A, Grube M, Jedlitschky G, Fischer A, Strohmeier B, Eiden M et al (2014) St. John’s Wort reduces beta-amyloid accumulation in a double transgenic Alzheimer's disease mouse model-role of P-glycoprotein. Brain Pathol 24:18–24
Article
Google Scholar
Johnsen KB, Gudbergsson JM, Skov MN, Pilgaard L, Moos T, Duroux M (2014) A comprehensive overview of exosomes as drug delivery vehicles—endogenous nanocarriers for targeted cancer therapy. Biochim Biophys Acta 1846:75–87
CAS
PubMed
Google Scholar
Cui GH, Guo HD, Li H, Zhai Y, Gong ZB, Wu J et al (2019) RVG-modified exosomes derived from mesenchymal stem cells rescue memory deficits by regulating inflammatory responses in a mouse model of Alzheimer's disease. Immun Ageing 16:10
Article
Google Scholar
Zheng Y, He R, Wang P, Shi Y, Zhao L, Liang J (2019) Exosomes from LPS-stimulated macrophages induce neuroprotection and functional improvement after ischemic stroke by modulating microglial polarization. Biomater Sci 7:2037–2049
CAS
Article
Google Scholar
Wang H, Sui H, Zheng Y, Jiang Y, Shi Y, Liang J et al (2019) Curcumin-primed exosomes potently ameliorate cognitive function in AD mice by inhibiting hyperphosphorylation of the Tau protein through the AKT/GSK-3beta pathway. Nanoscale 11:7481–7496
CAS
Article
Google Scholar
Yang J, Zhang X, Chen X, Wang L, Yang G (2017) Exosome mediated delivery of miR-124 promotes neurogenesis after ischemia. Mol Ther Nucleic Acids 7:278–287
CAS
Article
Google Scholar
Zhao L, Li H, Shi Y, Wang G, Liu L, Su C et al (2015) Nanoparticles inhibit cancer cell invasion and enhance antitumor efficiency by targeted drug delivery via cell surface-related GRP78. Int J Nanomedicine 10:245–256
PubMed
Google Scholar
Lim HS, Kim YJ, Sohn E, Yoon J, Kim BY, Jeong SJ (2018) Bojungikgi-tang, a traditional herbal formula, exerts neuroprotective effects and ameliorates memory impairments in Alzheimer’s disease-like experimental models. Nutrients 10:1952
Article
Google Scholar
Zhang X, Wang X, Hu X, Chu X, Li X, Han F (2019) Neuroprotective effects of a Rhodiola crenulata extract on amyloid-beta peptides (Abeta1-42)-induced cognitive deficits in rat models of Alzheimer's disease. Phytomedicine 57:331–338
CAS
Article
Google Scholar
Vorhees CV, Williams MT (2006) Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc 1:848–858
Article
Google Scholar
Sahay G, Alakhova DY, Kabanov AV (2010) Endocytosis of nanomedicines. J Control Release 145:182–195
CAS
Article
Google Scholar
Sahay G, Kim JO, Kabanov AV, Bronich TK (2010) The exploitation of differential endocytic pathways in normal and tumor cells in the selective targeting of nanoparticulate chemotherapeutic agents. Biomaterials 31:923–933
CAS
Article
Google Scholar
Provias J, Jeynes B (2014) The role of the blood-brain barrier in the pathogenesis of senile plaques in Alzheimer's disease. Int J Alzheimers Dis 2014:191863
CAS
PubMed
PubMed Central
Google Scholar
Park R, Kook SY, Park JC, Mook-Jung I (2014) Abeta1–42 reduces P-glycoprotein in the blood-brain barrier through RAGE-NF-kappaB signaling. Cell Death Dis 5:e1299
CAS
Article
Google Scholar
Reza-Zaldivar EE, Hernández-Sapiéns MA, Minjarez B, Gutiérrez-Mercado YK, Márquez-Aguirre AL, Canales-Aguirre AA (2018) Potential effects of MSC-derived exosomes in neuroplasticity in Alzheimer’s disease. Front Cell Neurosci 12:317
CAS
Article
Google Scholar
Iranifar E, Seresht BM, Momeni F, Fadaei E, Mehr MH, Ebrahimi Z, Rahmati M, Kharazinejad E, Mirzaei H (2019) Exosomes and microRNAs: new potential therapeutic candidates in alzheimer disease therapy. J Cell Physiol 234:2296–2305
CAS
Article
Google Scholar